Lisinopril
Rank #118 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$145.8M
Total Cost
15,744,768
Total Claims
$145.8M
Total Cost
136,262
Prescribers
$9
Cost per Claim
4,612,690
Beneficiaries
38,736,759
30-Day Fills
$1,070
Avg Cost/Provider
116
Avg Claims/Provider
Share of Medicare Part D Spending
0.05%
of total Medicare Part D spending
$145.8M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $145.8M total
🔎 Data Overview
At $9.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Lisinopril
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Isaac Snapp | Physician Assistant | Darlington, SC | 77 | $100K |
| 2 | Isabel Mendoza | Family Practice | Darlington, SC | 66 | $58K |
| 3 | Brian Heaster | Internal Medicine | Darlington, SC | 54 | $50K |
| 4 | Krista Heckert | Nurse Practitioner | Saginaw, MI | 12 | $45K |
| 5 | Smita Mandal | Internal Medicine | Simi Valley, CA | 12 | $32K |
| 6 | Lisa Seeber | Family Practice | Virginia, MN | 12 | $31K |
| 7 | Donald Vollmer | Family Practice | Hendersonville, TN | 4,378 | $28K |
| 8 | Sara Mixter | Internal Medicine | Baltimore, MD | 12 | $26K |
| 9 | Terence Frinks | Family Practice | Tucker, GA | 3,771 | $25K |
| 10 | Joshua Murphy | Nurse Practitioner | Lamar, SC | 19 | $24K |
| 11 | Ashley Theroux | Nurse Practitioner | Haverhill, MA | 2,202 | $24K |
| 12 | Jose Bautista | Internal Medicine | Sanger, CA | 1,253 | $23K |
| 13 | Najmuddin Karimjee | Internal Medicine | Houston, TX | 2,796 | $23K |
| 14 | Michael Satchell | Family Practice | Albany, GA | 4,076 | $22K |
| 15 | Andrew Graf | Internal Medicine | Plymouth Meeting, PA | 3,024 | $22K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 115 | Ixekizumab (Taltz Autoinjector) | $149.8M | 19,972 |
| 116 | Sofosbuvir/Velpatasvir (Epclusa) | $149.4M | 6,544 |
| 117 | Dolutegravir/Rilpivirine (Juluca) | $148.9M | 41,081 |
| 118 | Lisinopril (Lisinopril) | $145.8M | 15,744,768 |
| 119 | Ofatumumab (Kesimpta Pen) | $144.6M | 14,774 |
| 120 | Emtricitab/Rilpiviri/Tenof Ala (Odefsey) | $144.1M | 37,441 |
| 121 | Eltrombopag Olamine (Promacta) | $142.8M | 10,876 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology